Tag: https://www.bio.org/events/bio-international-convention

House Oversight Committee hearing “Assessing America’s Vaccine Safety Systems, Part 1. (Feb. 15, 2024) source

source

BIO Vice Chair (and incoming CEO) John F. Crowley speaks at the Reagan-Udall Foundation for the FDA workshop about qualifying biomarkers to support rare disease regulatory pathways. (Feb. 21, 2024) source

source

Genetic Medicines’ Path to Scalability for Patients and Investors source

Opportunities for Financing Your Company Through Series B and Beyond source

Tackling Challenges in Oncology Drug Discovery and Development source

source

Connecting Investors and Patient Advocacy Groups: An Overview of Funding New Therapies source

Policy Outlook: Understanding the Environment for Pricing and Access to Medicines During an Election Year. source